Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $2.63 billion. The enterprise value is $2.18 billion.
| Market Cap | 2.63B |
| Enterprise Value | 2.18B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 143.99 million shares outstanding. The number of shares has increased by 23.52% in one year.
| Current Share Class | 143.99M |
| Shares Outstanding | 143.99M |
| Shares Change (YoY) | +23.52% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 3.19% |
| Owned by Institutions (%) | 64.41% |
| Float | 107.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.32 |
| Forward PS | 120.92 |
| PB Ratio | 6.52 |
| P/TBV Ratio | 7.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.67.
| Current Ratio | 3.34 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -43.18 |
Financial Efficiency
Return on equity (ROE) is -114.11% and return on invested capital (ROIC) is -50.88%.
| Return on Equity (ROE) | -114.11% |
| Return on Assets (ROA) | -33.13% |
| Return on Invested Capital (ROIC) | -50.88% |
| Return on Capital Employed (ROCE) | -76.74% |
| Weighted Average Cost of Capital (WACC) | 9.68% |
| Revenue Per Employee | $166,389 |
| Profits Per Employee | -$753,744 |
| Employee Count | 601 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.44% in the last 52 weeks. The beta is 1.09, so RCUS's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -7.44% |
| 50-Day Moving Average | 23.75 |
| 200-Day Moving Average | 24.57 |
| Relative Strength Index (RSI) | 36.97 |
| Average Volume (20 Days) | 2,709,725 |
Short Selling Information
The latest short interest is 12.36 million, so 8.58% of the outstanding shares have been sold short.
| Short Interest | 12.36M |
| Short Previous Month | 13.81M |
| Short % of Shares Out | 8.58% |
| Short % of Float | 11.53% |
| Short Ratio (days to cover) | 8.16 |
Income Statement
In the last 12 months, RCUS had revenue of $100.00 million and -$453.00 million in losses. Loss per share was -$3.64.
| Revenue | 100.00M |
| Gross Profit | -373.00M |
| Operating Income | -475.00M |
| Pretax Income | -453.00M |
| Net Income | -453.00M |
| EBITDA | -465.00M |
| EBIT | -475.00M |
| Loss Per Share | -$3.64 |
Balance Sheet
The company has $630.00 million in cash and $241.00 million in debt, with a net cash position of $453.00 million or $3.15 per share.
| Cash & Cash Equivalents | 630.00M |
| Total Debt | 241.00M |
| Net Cash | 453.00M |
| Net Cash Per Share | $3.15 |
| Equity (Book Value) | 358.00M |
| Book Value Per Share | 2.81 |
| Working Capital | 465.00M |
Cash Flow
In the last 12 months, operating cash flow was -$465.00 million and capital expenditures -$1.00 million, giving a free cash flow of -$466.00 million.
| Operating Cash Flow | -465.00M |
| Capital Expenditures | -1.00M |
| Depreciation & Amortization | 10.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -466.00M |
| FCF Per Share | -$3.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | -475.00% |
| Pretax Margin | -453.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.52% |
| Shareholder Yield | -23.52% |
| Earnings Yield | -19.93% |
| FCF Yield | -17.70% |
Analyst Forecast
The average price target for RCUS is $41.25, which is 125.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.25 |
| Price Target Difference | 125.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | -24.52% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of -0.4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.4 |
| Piotroski F-Score | n/a |